Tag: life sciences
-
Off-the-Shelf Stem Cell Company Forms, Gains $72M
A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds.
-
Gene Therapy Delivery Company Gains $26M in Early Funds
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round.
-
Trial Underway Testing Cancer Drug as Covid-19 Therapy
A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections.
-
Animal Genome Biotech Raises $9M in Seed Funds
A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds.
-
Delivery Tech Licensed for CBD Epilepsy Nasal Spray
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain.
-
Infographic – Digital Therapeutics Funding on the Rise
The technology intelligence company CB Insights reported on new investments in digital therapeutics and found a record-setting funding pace this year.
-
Neuroscience Software Company Raises $23M in Early Funds
A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round.
-
FDA Okays One-Time HIV Treatment Clinical Trial
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial.
-
Trial Shows VR Training Helps Correct Lazy Eye in Kids
Clinical trial findings show a digital therapy using virtual reality headsets improves vision in children with amblyopia, or lazy eye, more than corrective lenses alone.
-
Gene-Edited Treatments in Works for Safer Cancer Therapies
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies.